CUTANEOUS AMYLOIDOSIS

This adverse event was reported 84 times

These drugs are most commonly taken by patients reporting CUTANEOUS AMYLOIDOSIS:

# Drug Count
0 INSULIN GLARGINE 36
1 INSULIN LISPRO 25
2 INSULIN GLARGINE-YFGN 11
3 ANAKINRA 6
4 METHOTREXATE SODIUM 6
5 HUMAN INSULIN 5
6 INSULIN ASPART 5
7 METHOTREXATE 5
8 INSULIN DEGLUDEC 4
9 INSULIN HUMAN 4
See all common drugs associated with CUTANEOUS AMYLOIDOSIS

CUTANEOUS AMYLOIDOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HUMAN INSULIN 5 0.0007
1 PIMECROLIMUS 1 0.0006
2 INSULIN GLARGINE-YFGN 11 0.0005
3 FOSINOPIRL SODIUM 1 0.0005
4 ANAKINRA 6 0.0004
5 FOSINOPRIL 1 0.0002
6 INSULIN GLULISINE 2 0.0002
7 CANAKINUMAB 2 0.0002
8 CLINDAMYCIN PHOSPHATE 1 0.0002
9 INSULIN LISPRO 25 0.0002
See all drugs enriched for association with CUTANEOUS AMYLOIDOSIS